Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...

Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat the disease’s ongoing spread throughout the country. Over 100,000 people ...

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based ...

Automakers have long touted the benefits of fuel injection, claiming increased efficiency and power. But as more cars have the system installed (around 73% in 2023), more and more consumers are ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...

The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...

Run src/main/resources/schema.sql to create tables and insert data. Copy database.properties.cfg to database.properties in the same resources folder and configure ...

Lenacapavir, a bi-annual injectable treatment for HIV prevention (PrEP), is being celebrated as a major advancement in the field following new study results showing a 96% reduction in HIV cases. The ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...